EUVIMEDEUVIMED entdecken
Crossref

Pretreatment with Notoginsenoside R1 attenuates high‐altitude hypoxia‐induced cardiac injury via activation of the ERK1 / 2‐P90RSK‐Bad signaling pathway in rats

Sijing Zhao iD, Nan Jia, Zherui Shen, Caixia Pei, Demei Huang, Junling Liu, Yilan Wang iD, Shihua Shi iD, Xiaomin Wang, Mingjie Wang, Yacong He iD, Zhenxing Wang iD

Phytotherapy Research · 2023

DOI: 10.1002/ptr.7923 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Sijing Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Ginsenosides, MAP Kinase Signaling System, Altitude Sickness, Heart Injuries. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 123 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Research Project of Sichuan Provincial Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High‐altitude cardiac injury (HACI) is one of the common tissue injuries caused by high‐altitude hypoxia that may be life threatening. Notoginsenoside R1 (NG‐R1), a major saponin of Panax notoginseng, exerts anti‐oxidative, anti‐inflammatory, and anti‐apoptosis effects, protecting the myocardium from hypoxic injury. This study aimed to investigate the protective effect and molecular mechanism of NG‐R1 against HACI. We simulated a 6000 m environment for 48 h in a hypobaric chamber to create a HACI rat model. Rats were pretreated with NG‐R1 (50, 100 mg/kg) or dexamethasone (4 mg/kg) for 3 days and then placed in the chamber for 48 h. The effect of NG‐R1 was evaluated by changes in Electrocardiogram parameters, histopathology, cardiac biomarkers, oxidative stress and inflammatory indicators, key protein expression, and immunofluorescence. U0126 was used to verify whether the anti‐apoptotic effect of NG‐R1 was related to the activation of ERK pathway. Pretreatment with NG‐R1 can improve abnormal cardiac electrical conduction and alleviate high‐altitude‐induced tachycardia. Similar to dexamethasone, NG‐R1 can improve pathological damage, reduce the levels of cardiac injury biomarkers, oxidative stress, and inflammatory indicators, and down‐regulate the expression of hypoxia‐related proteins HIF‐1α and VEGF. In addition, NG‐R1 reduced cardiomyocyte apoptosis by down‐regulating the expression of apoptotic proteins Bax, cleaved caspase 3, cleaved caspase 9, and cleaved PARP1 and up‐regulating the expression of anti‐apoptotic protein Bcl‐2 through activating the ERK1/2‐P90RSK‐Bad pathway. In conclusion, NG‐R1 prevented HACI and suppressed apoptosis via activation of the ERK1/2‐P90RSK‐Bad pathway, indicating that NG‐R1 has therapeutic potential to treat HACI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesMAP Kinase Signaling SystemAltitude SicknessHeart InjuriesAnimalsMaleRatsRats, Sprague-DawleyApoptosisOxidative StressSignal TransductionHypoxiaAltitudePanax notoginseng

Stichwörter der Autor:innen

apoptosiscardiac injuryhigh altitudehypoxia

Substanzen

Ginsenosidesnotoginsenoside R1

Autor:innen und Institutionen

  • Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
  • School of Traditional Chinese Medicine, Chongqing Medical and Pharmaceutical College, Chongqing, China.
  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

ORCID-Profile: Sijing Zhao, Yilan Wang, Shihua Shi, Yacong He, Zhenxing Wang

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Research Project of Sichuan Provincial Administration of Traditional Chinese Medicine

Zitieren

APA

Zhao, S., Jia, N., Shen, Z., Pei, C., Huang, D., Liu, J., Wang, Y., Shi, S., Wang, X., Wang, M., He, Y., & Wang, Z. (2023). Pretreatment with Notoginsenoside R1 attenuates high‐altitude hypoxia‐induced cardiac injury via activation of the ERK1 / 2‐P90RSK‐Bad signaling pathway in rats. Phytotherapy Research. https://doi.org/10.1002/ptr.7923

Vancouver

Zhao S, Jia N, Shen Z, Pei C, Huang D, Liu J, et al. Pretreatment with Notoginsenoside R1 attenuates high‐altitude hypoxia‐induced cardiac injury via activation of the ERK1 / 2‐P90RSK‐Bad signaling pathway in rats. Phytotherapy Research. 2023. doi:10.1002/ptr.7923

BibTeX
@article{Zhao2023,
  author = {Zhao, Sijing and Jia, Nan and Shen, Zherui and Pei, Caixia and Huang, Demei and Liu, Junling and Wang, Yilan and Shi, Shihua and Wang, Xiaomin and Wang, Mingjie and He, Yacong and Wang, Zhenxing},
  title = {Pretreatment with Notoginsenoside R1 attenuates high‐altitude hypoxia‐induced cardiac injury via activation of the ERK1 / 2‐P90RSK‐Bad signaling pathway in rats},
  journal = {Phytotherapy Research},
  year = {2023},
  doi = {10.1002/ptr.7923}
}
Kostenlos starten →